Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
D 14.65 -2.01% -0.30
ABOS closed down 2.01 percent on Wednesday, August 4, 2021, on 42 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical ABOS trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Hot IPO Pullback Bullish Swing Setup -2.01%
Inside Day Range Contraction -2.01%
Wide Bands Range Expansion -2.01%
Hot IPO Pullback Bullish Swing Setup -4.06%
Older End-of-Day Signals for ABOS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 18 hours ago
Hot IPO Pullback Entry about 20 hours ago
Rose Above Previous Day's High about 20 hours ago
10 DMA Resistance about 20 hours ago
Up 5% about 20 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Neurodegeneration Amyloid Regulus Therapeutics Amyloidosis Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta

Is ABOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.98
52 Week Low 13.95
Average Volume 194,246
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 16.91
10-Day Moving Average 15.59
Average True Range 1.95
ADX 0.0
+DI 12.96
-DI 18.23
Chandelier Exit (Long, 3 ATRs) 14.75
Chandelier Exit (Short, 3 ATRs) 19.79
Upper Bollinger Bands 20.02
Lower Bollinger Band 13.81
Percent B (%b) 0.14
BandWidth 36.71
MACD Line -1.49
MACD Signal Line -1.05
MACD Histogram -0.4447
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.75
Resistance 3 (R3) 16.97 16.49 16.40
Resistance 2 (R2) 16.49 15.96 16.38 16.28
Resistance 1 (R1) 15.57 15.62 15.33 15.35 16.17
Pivot Point 15.09 15.09 14.97 14.98 15.09
Support 1 (S1) 14.17 14.56 13.93 13.95 13.13
Support 2 (S2) 13.69 14.22 13.58 13.02
Support 3 (S3) 12.77 13.69 12.90
Support 4 (S4) 12.55